Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EEF2K | O00418 | 4/20 | 0.37 |
| ▸ | CTSA | P10619 | 6/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.35 |
| ▸ | ITGAV | P06756 | 4/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | OGT | O15294 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7789956 | 0.89 | EEF2K (0.39) | EEF2KITGB3ITGAVATML3MBTL1 | |
| SCHEMBL7788758 | 0.89 | ALDH1A1 (0.38) | EEF2KCTSAITGB3ITGAVATM | |
| SCHEMBL7781105 | 0.84 | EEF2K (0.47) | EEF2KITGB3ITGAVATML3MBTL1 | |
| SCHEMBL7786192 | 0.80 | EEF2K (0.52) | EEF2KITGB3ITGAVATML3MBTL1 | |
| SCHEMBL7785590 | 0.80 | ATM (0.42) | EEF2KITGB3ITGAVATML3MBTL1 | |
| SCHEMBL7785619 | 0.80 | ATM (0.42) | EEF2KITGB3ITGAVATML3MBTL1 | |
| SCHEMBL7786214 | 0.80 | S1PR3 (0.41) | CTSAITGB3ALDH1A1ITGA2B | |
| SCHEMBL7194899 | 0.80 | ITGB3 (0.44) | CTSAITGB3ITGAVALDH1A1LMNA | |
| SCHEMBL7785625 | 0.80 | EEF2K (0.41) | EEF2KITGB3ITGAVATML3MBTL1 | |
| SCHEMBL7788304 | 0.79 | ITGB3 (0.42) | CTSAITGB3ITGAVITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1147079-A2 | BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS | Bayer Aktiengesellschaft (DE) | 2001-10-24 | — | — | EP | disclosed |
| WO-2000041469-A2 | β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-07-20 | — | — | WO | disclosed |